Autolus Therapeutics plc Gains 35.47%
Wed, May 12, 2021 at 05:33 PM
Autolus Therapeutics plc (AUTL:NASDAQ) soared at $6.76, a gain of 35.5%. On Tue, May 11, 2021, AUTL:NASDAQ touched a New 2-Week Intraday Low of $4.62. The stock appeared on our News Catalysts scanner on Wed, May 12, 2021 at 10:33 AM in the 'MISCELLANEOUS' category. From Tue, Apr 27, 2021, the stock recorded 30.00% Up Days and 36.36% Green Days
The share price of the company has been moving sideways in recent weeks.
About Autolus Therapeutics plc (AUTL:NASDAQ)
Autolus Therapeutics PLC is a biopharmaceutical company. It is engaged in the development of next-generation programmed T cell therapies for the treatment of cancer. The company's pipeline includes AUTO1, AUTO2, AUTO3, AUTO4, and AUTO6.
Top 10 Gainers:
- REVH (REVH:NASDAQ), 2074.47%
- Curis, Inc. (CRIS:NASDAQ), 65.51%
- LHDX (LHDX:NASDAQ), 44.2%
- Autolus Therapeutics plc (AUTL:NASDAQ), 35.47%
- Summit Wireless Technologies, Inc. (WISA:NASDAQ), 31.01%
- Second Sight Medical Products, Inc. (EYES:NASDAQ), 27.6%
- ShotSpotter, Inc. (SSTI:NASDAQ), 25.39%
- Barnwell Industries, Inc. (BRN:NYSEMKT), 23.97%
- LRMR (LRMR:NASDAQ), 23.68%
- Ra Medical Systems, Inc. (RMED:NYSE), 18.07%